← Back to catalogue

INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use)

FDA UDI

Class II (US FDA UDI)

by Alfa Scientific Designs, Inc.

Identity

Trade Name
INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) FDA UDI
Generic Name
Multiple drugs of abuse IVD, kit, rapid ICT, clinical FDA UDI
Device Name
INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) AMP COC MET MOR PCP THC XTC FDA UDI
Model / Reference
03-4703 FDA UDI
Description
INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) AMP COC MET MOR PCP THC XTC FDA UDI

Identifiers

Primary DI / UDI-DI
10796918001952 FDA UDI
FDA Product Code
DKE FDA UDI
LCM FDA UDI
DOE FDA UDI
DJC FDA UDI
DIO FDA UDI
DKZ FDA UDI
GMDN Term
Multiple drugs of abuse IVD, kit, rapid ICT, clinical FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
862.3870 FDA UDI
862.3640 FDA UDI
862.3610 FDA UDI
862.3250 FDA UDI
862.3100 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple drugs of abuse IVD, kit, rapid ICT, clinical

INSTANT-VIEW plus Multi-Drug Urine Test - Simple Cup (Prescription Use) by Alfa Scientific Designs, Inc. — Class II — FDA UDI — listed in FDA GUDID

Similar devices

Also classified as Multiple drugs of abuse IVD, kit, rapid ICT, clinical.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 084e3b5f-9665-4294-b2ac-26b31866ba66 33 fields · synced Jun 9, 2026